BRIEF-Adamas Announces Final Results From Phase 3 Open-Label Study Of Gocovri
April 19, 2018 at 05:32 AM EDT
* ADAMAS ANNOUNCES FINAL RESULTS FROM THE TWO-YEAR PHASE 3 OPEN-LABEL STUDY OF GOCOVRI™ IN PARKINSON’S DISEASE PATIENTS WITH DYSKINESIA
